April 29, 2025

AACR 2025: Pretrained AI Models Could Help Accurately Diagnose Nonmelanoma Skin Cancers in Resource-Limited Settings

Researchers explored whether artificial intelligence (AI) models pretrained on vast data sets may outperform standard baseline models in identifying nonmelanoma skin cancers, according to findings pre...

The ASCO Post

April 26, 2024

Vladimir Botchkarev, MD, PhD, Honored With 2023 Skin Ageing & Challenges Best Scientific Award

Vladimir Botchkarev received the 2023 Skin Ageing & Challenges Best Scientific Award.

Conexiant

March 10, 2025

Baricitinib Effective for Teen Alopecia

Eli Lilly's JAK inhibitor demonstrated 80% scalp hair regrowth in 42.4% of adolescents with severe alopecia areata after just 36 weeks of treatment, outperforming placebo in the Phase 3 BRAVE-AA-PEDS trial.

Conexiant

December 30, 2024

Nutrafol Safety Signal Emerges in Case Study

A previously healthy 26-year-old developed severe liver injury after using Nutrafol, with a biopsy confirming marked necroinflammatory damage with complete resolution upon discontinuation.

Conexiant

April 29, 2024

Identifying Common Triggers of Photocontact Dermatitis

Discover how exposure to certain fruits, vegetables, drugs, and plants can trigger symptoms of photocontact dermatitis and the importance of seeking shade and wearing protective clothing in the sun.

Conexiant

April 29, 2024

New Strategies to Manage and Minimize Exposure to HIV, Other STIs; Advance Gender-Affirming Care

New treatments for HIV and STIs in LGBTQ+ patients, including novel preventive measures and dermatological care for transgender and gender-diverse patients, are highlighted in a recent AAD press release.

Conexiant

April 30, 2024

AAD 2024: AAD Welcomes Seemal R. Desai, MD, FAAD, as President

Seemal R. Desai, MD, FAAD, began his 1-year term as President of the American Academy of Dermatology (AAD) as well as its sister association the AAD Association at the conclusion of the 2024 AAD Annual Meeting.

Conexiant

April 17, 2024

RP1 Immunotherapy in Solid Organ Transplant Recipients with Skin Cancer

A novel oncolytic immunotherapy using a modified herpes simplex virus has shown promise in treating skin cancers in solid organ transplant recipients, offering potential alternative treatment, revealed at the AACR Annual Meeting 2024.

Conexiant

April 29, 2024

Novel Therapies May Represent the Future of Treating Cutaneous Autoimmune Diseases

Excitement is growing around emerging novel therapeutics for patients with dermatomyositis and cutaneous lupus erythematosus, as Dr. Anthony Fernandez predicts the start of an exciting decade in the history of these two diseases.

Conexiant